HHealth Read More Breath test for ‘deadliest’ cancer trialled in WrexhamAugust 27, 2026 A 30-second breath test that could detect pancreatic cancer is being trialled in Wrexham. Pancreatic cancer is the…
HHealthcare Read More Revolution Medicines gets FDA nod for targeted pancreatic cancer drugAugust 26, 2026 Menta “Steve” Wallace shows a bottle of daraxonrasib, Revolution Medicines’ pancreatic cancer drug, at his home in The…
MMovies Read More Sanjay Dutt’s mother Nargis was in Coma and Sunil Dutt sent him to complete his debut film, the actor recalls traumatic time during his mother’s final days: ‘I was 19-20 years, just couldn’t understand it’ |July 30, 2026 Sanjay Dutt has seldom spoken in detail about the personal tragedies that shaped his life. While the actor…
HHealth Read More Engineered probiotic bacteria boost immune attack against pancreatic cancerJuly 25, 2026 Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to treat. One major…
MMedication Read More Revolution Medicines’ New Drug Application for Daraxonrasib Accepted for Review by U.S. FDA for Previously Treated Metastatic Pancreatic CancerJuly 24, 2026 Revolution Medicines, Inc. REDWOOD CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
MMedication Read More European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review ProcessJuly 8, 2026 Revolution Medicines, Inc. REDWOOD CITY, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
MMedication Read More Why Revolution Medicines (RVMD) Is Up 6.2% After Early Zoldonrasib Pancreatic Cancer Data And What’s NextJuly 4, 2026 In late June and early July 2026, Revolution Medicines reported Phase 1/2 data showing that its RAS G12D…
MMedication Read More Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026July 2, 2026 Revolution Medicines, Inc. REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
HHealthcare Read More New pancreatic cancer drug daraxonrasib shows breakthrough in survivalJune 5, 2026 A doctor talks with a patient. Treatment options and survival rates for people with pancreatic cancer are improving…
HHealth Read More Pancreatic cancer pill that doubled survival may get Canada clinical trial – NationalJune 3, 2026 The head of pancreatic cancer at Princess Margaret Cancer Centre says she hopes clinical trials for a pill…
HHealth Read More Experimental pill promises new hope for deadly pancreatic cancerMay 31, 2026 WASHINGTON (AP) — A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising…
MMedication Read More How FDA Expanded Access for Daraxonrasib and Phase 3 Survival Data At Revolution Medicines (RVMD) Has Changed Its Investment StoryMay 6, 2026 Revolution Medicines recently secured FDA clearance for an expanded access program for its investigational pancreatic cancer drug daraxonrasib,…